DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor–resistant lung cancer therapy
Haejeong Heo(Korea Research Institute of Bioscience and Biotechnology), Mirang Kim(Korea Research Institute of Bioscience and Biotechnology)
Cited by 17
Related Papers
Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
|Cancer Medicine|2018|23